Hematopoietic Commitment: Molecular Mechanisms
造血承诺:分子机制
基本信息
- 批准号:6845676
- 负责人:
- 金额:$ 30.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-01-01 至 2007-12-31
- 项目状态:已结题
- 来源:
- 关键词:AP1 proteinNOD mouseSCID mouseactivinsangiogenesisbiological signal transductionbone morphogenetic proteinscell differentiationchromatin immunoprecipitationdevelopmental geneticsembryogenesisembryonic stem cellenzyme activityfibroblast growth factorgene expressiongenetic regulationgenetically modified animalsgrowth factor receptorshematopoiesishematopoietic stem cellsprotein protein interactionprotein structure functiontranscription factorvascular endothelial growth factors
项目摘要
DESCRIPTION (provided by applicant): Our long-term goal is to understand how the hematopoietic system is established in the developing embryo. Our studies of in vitro differentiated embryonic stem (ES) cells indicate that the hematopoietic system is established via distinct, sequentially generated Flk-1 and SCL-expressing cells. Flk-I+SCL - cells first arise in developing embryoid bodies (EBs, in vitro differentiated progeny of ES cells). The Scl gene is turned on within Flk-1 + SCL- cells to give rise to Flk-1 + SCL + cells. The hemangioblast cell population, a common progenitor of hematopoietic and endothelial cells, was enriched within these cells. Within Flk-I+SCL + cells, Flk-1 is down regulated to finally generate Flk-I-SCL + hematopoietic progenitors. A serum free in vitro differentiation model of ES cells has identified that bone morphogenetic protein (BMP) -4 is critical in the generation of Flk-1 + and SCL + cells. Many studies implicate the importance of BMP-4 in hematopoietic development. However, none of the studies examined the precise developmental stage in which the BMP-4 functions. Our proposal is to further characterize molecular mechanisms controlling Flk-1 and Scl expression and to determine the precise developmental stage where BMP-4 functions to establish the hematopoietic system.
Specific aim I: Further characterize molecular events involved in the generation of Flk-1 + and SCL + cells. Our studies indicate that the activation of both map kinase and Smadl pathways by BMP-4 is critical for the generation of Flk-1 + cells. Furthermore, recent studies suggest that the transcription factor GATA-2 is one component that binds Scl enhancer region. Thus, our aim is to further understand mechanisms controlling Flk-1 and Scl gene expression.
Specific aim II. Examine the role of BMP-4 mediated signals in hemangioblast development. Our experiments indicate that BMP-4 is critical for the generation of Flk-1 + cells. What is not clear from our current studies is whether BMP-4 mediated signals are still required after the Flk-I + cell stage in establishing hematopoiesis. Our specific aim is to utilize Flk-l-cre mice and conditional Alk-3 (BMP-4 receptor) knockout mice to determine whether BMP-4 mediated signals are obligatory for the generation of the hemangioblast within the Flk-1 + cells.
Specific aim III. Examine the role of BMP-4 mediated signals in hematopoietic and endothelial cell development. Subsequent to hemangioblast development, hematopoietic and endothelial cell lineage commitment commences. Our specific aim is to determine whether BMP-4 mediated signals are required for hematopoietic lineage commitment from the hemangioblast. Scl-cre mice and conditional Alk-3 knockout mice will be utilized.
描述(由申请人提供):我们的长期目标是了解如何在发育中的胚胎中建立造血系统。我们对体外分化的胚胎(ES)细胞的研究表明,造血系统是通过不同的,依次生成的FLK-1和表达SCL的细胞建立的。 FLK -I+SCL-细胞首先出现在发育的胚胎体(EBS,体外分化ES细胞的后代)中。 SCL基因在FLK-1 + SCL-细胞内打开,产生FLK-1 + SCL +细胞。血管细胞细胞群是造血和内皮细胞的常见祖细胞,在这些细胞中富集。在FLK-I + SCL +细胞中,FLK-1被下调以最终产生FLK-I-SCL +造血祖细胞。 ES细胞的无血清体外分化模型已经确定,骨形态发生蛋白(BMP)-4对于FLK -1 +和SCL +细胞的产生至关重要。许多研究暗示了BMP-4在造血发育中的重要性。但是,没有研究研究BMP-4功能的确切发育阶段。我们的建议是进一步表征控制FLK-1和SCL表达的分子机制,并确定BMP-4功能建立造血系统的精确发育阶段。
具体目的I:进一步表征与FLK-1 +和SCL +细胞产生的分子事件。我们的研究表明,BMP-4的MAP激酶和SMADL途径的激活对于FLK-1 +细胞的产生至关重要。此外,最近的研究表明,转录因子GATA-2是结合SCL增强子区域的组成部分。因此,我们的目的是进一步了解控制FLK-1和SCL基因表达的机制。
具体目标II。检查BMP-4介导的信号在血管细胞发育中的作用。我们的实验表明,BMP-4对于FLK-1 +细胞的产生至关重要。从我们目前的研究中尚不清楚的是,在建立造血的FLK-I +细胞阶段后是否仍需要BMP-4介导的信号。我们的具体目的是利用FLK-L-CRE小鼠和条件ALK-3(BMP-4受体)基因敲除小鼠来确定BMP-4介导的信号是否对在FLK-1 +细胞中生成血管生成的信号是必不可少的。
特定目标III。检查BMP-4介导的信号在造血和内皮细胞发育中的作用。在血管细胞发育,造血和内皮细胞谱系承诺之后开始。我们的具体目的是确定血管细胞造血谱系承诺是否需要BMP-4介导的信号。 SCL-CRE小鼠和有条件的ALK-3基因敲除小鼠将被使用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KYUNGHEE CHOI其他文献
KYUNGHEE CHOI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KYUNGHEE CHOI', 18)}}的其他基金
Epigenetic regulations of macrophage development
巨噬细胞发育的表观遗传调控
- 批准号:
10320843 - 财政年份:2020
- 资助金额:
$ 30.6万 - 项目类别:
Epigenetic regulations of macrophage development
巨噬细胞发育的表观遗传调控
- 批准号:
10541848 - 财政年份:2020
- 资助金额:
$ 30.6万 - 项目类别:
Epigenetic regulations of macrophage development
巨噬细胞发育的表观遗传调控
- 批准号:
10083228 - 财政年份:2020
- 资助金额:
$ 30.6万 - 项目类别:
DIRECTED DIFFERENTIATION OF ES AND IPS CELLS TO HEMATOPOIETIC STEM CELLS
ES 和 IPS 细胞定向分化为造血干细胞
- 批准号:
8205822 - 财政年份:2011
- 资助金额:
$ 30.6万 - 项目类别:
DIRECTED DIFFERENTIATION OF ES AND IPS CELLS TO HEMATOPOIETIC STEM CELLS
ES 和 IPS 细胞定向分化为造血干细胞
- 批准号:
8293183 - 财政年份:2011
- 资助金额:
$ 30.6万 - 项目类别:
相似国自然基金
mir-125b在1型糖尿病自身免疫性胰岛炎中的作用及机制研究
- 批准号:30901627
- 批准年份:2009
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Deciphering the role of mitochondrial/autophagy dysfunction in regulating inflammatory processes during AMD pathogenesis
破译线粒体/自噬功能障碍在 AMD 发病机制中调节炎症过程中的作用
- 批准号:
10664118 - 财政年份:2023
- 资助金额:
$ 30.6万 - 项目类别:
Exosomal Based micro RNA delivery for Resistant Lung Cancer
基于外泌体的 micro RNA 递送治疗耐药性肺癌
- 批准号:
10629892 - 财政年份:2023
- 资助金额:
$ 30.6万 - 项目类别:
Studies on Lineage Plasticity in Prostate Cancer
前列腺癌谱系可塑性的研究
- 批准号:
10722935 - 财政年份:2023
- 资助金额:
$ 30.6万 - 项目类别:
Investigating the role of CRAT as a driver of triple negative breast cancer chemoresistance
研究 CRAT 作为三阴性乳腺癌化疗耐药驱动因素的作用
- 批准号:
10536077 - 财政年份:2022
- 资助金额:
$ 30.6万 - 项目类别:
Development of a Companion Diagnostic Assay for Detection of ADAM8-Positive Cancers
开发用于检测 ADAM8 阳性癌症的伴随诊断测定法
- 批准号:
10685491 - 财政年份:2022
- 资助金额:
$ 30.6万 - 项目类别: